Stephen K. Doberstein
2010
In 2010, Stephen K. Doberstein earned a total compensation of $3.5M as Senior Vice President and Chief Scientific Officer at Nektar Therapeutics.
Compensation breakdown
| Bonus | $150,000 |
|---|---|
| Non-Equity Incentive Plan | $240,000 |
| Option Awards | $2,740,068 |
| Salary | $395,455 |
| Other | $7,818 |
| Total | $3,533,340 |
Doberstein received $2.7M in option awards, accounting for 78% of the total pay in 2010.
Doberstein also received $150K in bonus, $240K in non-equity incentive plan, $395.5K in salary and $7.8K in other compensation.
Rankings
In 2010, Stephen K. Doberstein's compensation ranked 1,629th out of 10,439 executives tracked by ExecPay. In other words, Doberstein earned more than 84.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,629 out of 10,439 | 84th |
Division Manufacturing | 578 out of 3,837 | 85th |
Major group Chemicals And Allied Products | 111 out of 923 | 88th |
Industry group Drugs | 65 out of 682 | 91st |
Industry Pharmaceutical Preparations | 53 out of 480 | 89th |
Source: SEC filing on April 30, 2012.
Doberstein's colleagues
We found four more compensation records of executives who worked with Stephen K. Doberstein at Nektar Therapeutics in 2010.